Preliminary Observation on Pagosid in Treatment of Osteoarthritis of Knee Joint and Retrograde Spondylitis
- VernacularTitle:帕歌斯治疗膝关节骨关节炎、退行性脊柱炎的初步观察
- Author:
Qiyun LI
- Publication Type:Journal Article
- From:
China Pharmacy
2001;12(3):166-167
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To verify the therapeutic effect of pagosid in treating osteoarthritis of knee joint and retrograde spondylitis METHODS: 60 patients were randomly divided into treatment group( pagosid) and control group( zulida) The clinical manifestations of osteoarthritis and spondylitis, including pain, joint dysfunction and swelling, were observed one month after treatment RESULTS: The total effective rates for osteoarthritis were 88 9% in treatment group and 82 4% in control group and those for spondylitis were 83 3% in treatment group and 81 8% in control group There were no statistical differences between two groups( P>0 05) CONCLUSION: Both pagosid and zulida have the therapeutic effects on inflammation, pain, swelling and dysfunction of joint, and pagosid does not induce adverse reactions, while zulida could result in considerable gastroenteric tract side reactions